Download PDF
1
/
Pages
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Hepatic Steatosis Index (HSI): A Valuable Biomarker in Subjects with Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD)
Bryan A. Priego-Parra; Arturo Triana-Romero; Génesis P. Martínez-Pérez; Sara A. Reyes-Diaz; Héctor R. Ordaz-Alvarez; Raúl Bernal-Reyes; María E. Icaza-Chávez; Sophia E. Martínez-Vázquez; Ana D. Cano-Contreras; Héctor Vivanco-Cid; José M. Remes-Troche;
Ann Hepatol. 2024;29 Supl 2:
Intrahepatic Cholestasis Induced by Leflunomide: An Unusual Presentation of DILI
Genesis P. Martínez-Pérez; Pamela Duran-Azamar; Ana D. Cano-Contreras; Peter Grube-Pagola; José M. Remes-Troche;
Ann Hepatol. 2024;29 Supl 2:
Prolonged-release pirfenidone in patients with compensated cirrhosis. Final results of the multicenter study ODISEA, controlled against placebo, plus standardized care_2023
Linda E. Munoz-Espinosa; Aldo Torre; Laura Cisneros; Iaarah Montalvo-Gordon; René Malé-Velázquez; Scherezada Mejía; Juan Ramón Aguilar-Ramírez; Javier Lizardi-Cervera; María E. Icaza-Chávez; Frida Gasca-Díaz; Larissa Hernández-Hernández; Paula Cordero-Perez; Luis A. Chi-Cervera; Lilian Torres-Made; Fátima Rodríguez-Álvarez; Graciela Tapia; Jorge Luis Poo;
Ann Hepatol. 2024;29 Supl 2: